| Jennifer Nicole Cruz, MOT, OTR/L | |
|
1512 Cerro Vista Rd Sw, Albuquerque, NM 87105-3006 | |
| (505) 870-3297 | |
| Not Available |
| Full Name | Jennifer Nicole Cruz |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1512 Cerro Vista Rd Sw, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093012767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2783 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Nicole Cruz, MOT, OTR/L 1512 Cerro Vista Rd Sw, Albuquerque, NM 87105-3006 Ph: (505) 870-3297 | Jennifer Nicole Cruz, MOT, OTR/L 1512 Cerro Vista Rd Sw, Albuquerque, NM 87105-3006 Ph: (505) 870-3297 |
News Archive
It appears that the public is still not embracing the new federal health law to the extent Democrats had hoped. As a result, Politico reports that Republican candidates for President and Congress may talk about the measure more than some Democrats — except, of course, when Democrats praise former Mass. Governor Mitt Romney for signing his home state's law.
Paclitaxel, a natural compound from yew trees, is the world's best-selling anticancer drug. Several analogs are in clinical trial, with others in preclinical development. One problem that paclitaxel and all its analogs share, however, is that they are all highly complex compounds, and cannot be prepared synthetically in a commercially viable way.
Patients benefitted from an important design element in the pivotal phase III clinical trial that led to Food and Drug Administration and worldwide regulatory approval of sunitinib for the treatment of gastrointestinal stromal tumors resistant to the only other available therapy, according to a study in Clinical Cancer Research, a journal of the American Association for Cancer Research.
BioControl Medical has announced U.S. Food and Drug Administration approval to begin the second phase of INOVATE-HF (INcrease Of VAgal TonE in Heart Failure), a global, multi-center, investigational device exemption (IDE) clinical study of the company's CardioFit system for heart failure.
› Verified 5 days ago
Sarah Day, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2722 Santa Monica Ave Se, Albuquerque, NM 87106 Phone: 505-702-6452 | |
Leslie Price, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2929 Coors Blvd Nw Ste 100, Albuquerque, NM 87120 Phone: 505-836-4899 Fax: 505-836-4844 | |
Diana Drawe, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 505 Elm St Ne, Albuquerque, NM 87102 Phone: 505-727-4725 | |
Tyler Paul Mason, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3830 Commons Ave Ne, Albuquerque, NM 87109 Phone: 502-542-4123 | |
Rebecca S Starrett, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5100 Marna Lynn Ave Nw, Petroglyph Es, Albuquerque, NM 87114 Phone: 505-898-0923 | |
Action Works Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1104 Idlewilde Ln Se, Albuquerque, NM 87108 Phone: 505-266-5724 | |
Sidney T Alley, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 601 4th St Sw, Coronado Complex, Albuquerque, NM 87102 Phone: 505-247-1012 |